e-learning
resources
Paris 2018
Monday, 17.09.2018
Latest developments in cystic fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis
N. Liu (London, United Kingdom), L. Miyashita (London, United Kingdom), J. Grigg (London, United Kingdom)
Source:
International Congress 2018 – Latest developments in cystic fibrosis
Session:
Latest developments in cystic fibrosis
Session type:
Poster Discussion
Number:
3413
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Liu (London, United Kingdom), L. Miyashita (London, United Kingdom), J. Grigg (London, United Kingdom). Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis. 3413
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Eosinophilic COPD
Related content which might interest you:
Carbon in airway macrophages and lung function in children
Source: Eur Respir Rev 2008; 17: 18-19
Year: 2008
Long-term clearance from small airways in patients with cystic fibrosis
Source: Eur Respir J 2005; 25: 317-323
Year: 2005
Carbon in the airway macrophages of children affected by chronic lower airway disease
Source: Annual Congress 2012 - Paediatric bronchology
Year: 2012
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006
Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis
Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017
Year: 2018
Expansion of small sputum macrophages in cystic fibrosis airways
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Oxidation contributes to low glutathione in the airways of children with cystic fibrosis
Source: Eur Respir J 2014; 44: 122-129
Year: 2014
The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020
Bronchial but not alveolar nitric oxide is decreased in adults with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005
Changes in lung gas mixing after physiotherapy in adults with cystic fibrosis
Source: Annual Congress 2007 - Critical care and airways clearance
Year: 2007
Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis
Source: Eur Respir J 2002; 20: 122-126
Year: 2002
Functional respiratory imaging assessment of the aerosol deposition of inhaled levofloxacin in cystic fibrosis lungs
Source: Virtual Congress 2021 – Cystic fibrosis
Year: 2021
Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014
Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis
Source: Eur Respir J 2003 Dec 01;22(6):972-979
Year: 2003
Airway inflammation in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 14-31
Year: 2014
Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis
Source: Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016
Year: 2017
Measurement of airways obstruction among preschoolers with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
Inhaled mannitol as treatment for children with cystic fibrosis
Source: Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept